Log in to save to my catalogue

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23aeb20596284c768ba2092668346e36

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

About this item

Full title

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

Publisher

Switzerland: MDPI AG

Journal title

Current oncology (Toronto), 2023-08, Vol.30 (9), p.7891-7903

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Multiple myeloma (MM) is a common hematological malignancy that has fostered several new therapeutic approaches to combat newly diagnosed or relapsed MM. While the field has advanced over the past 2 decades, the majority of patients will develop resistance to these treatments, causing the need for new therapeutic targets. SLAMF7 is an attractive th...

Alternative Titles

Full title

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_23aeb20596284c768ba2092668346e36

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_23aeb20596284c768ba2092668346e36

Other Identifiers

ISSN

1718-7729,1198-0052

E-ISSN

1718-7729

DOI

10.3390/curroncol30090573

How to access this item